What This Means
This research examined whether grouping heart attack (acute coronary syndrome, or ACS) patients into distinct biological 'types' based on their baseline characteristics, and whether simple scoring systems, could predict which patients were most likely to die over the following years. The study followed 3,561 patients admitted to a single hospital between 2017 and 2024, with a median follow-up of about 3.35 years, during which 407 patients died. Using a statistical clustering technique, researchers identified three patient groups ('phenotypes') with notably different death rates—about 4%, 12%, and 19%—but when they accounted for known clinical factors like age, kidney function, blood count, and heart function, most of the apparent differences between groups disappeared, and the groupings changed depending on which clustering method was used.
Three scoring systems—AAR-3, CARE-4, and ACEF—were each linked to higher mortality risk both in the first year and in subsequent years after a heart attack, and all three performed better than a simple age-based reference model. However, none of the three scores added meaningful predictive value beyond a model that already included age, hemoglobin, kidney function (eGFR), and heart pumping function (LVEF) measured as continuous variables. This suggests that the information captured by these scores largely overlaps with these four basic clinical measurements.
This research suggests that while clustering ACS patients into groups and using additive risk scores can reveal statistical patterns, these approaches have important limitations: the patient groupings are sensitive to the method used and may not reflect true biological differences, and the scoring systems—though associated with outcomes—have not been externally validated and should not yet be used to guide clinical decisions. The authors emphasize that multicenter prospective studies are needed before these tools can be applied in real-world patient care.